Oxford Asset Management’s Windtree Therapeutics Inc WINT Stock Holding History

Oxford Asset Management’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,504	Closed	-$100K	–	776
2015 Q2	$100K	Buy	10,504 +5,586	+114%	+$78.4K	﹤0.01%	619
2015 Q1	$82K	Sell	4,918 -2,169	-31%	-$42.7K	﹤0.01%	638
2014 Q4	$115K	Buy	+7,087	New	+$156K	﹤0.01%	646
2014 Q2	–	Sell	-4,936	Closed	-$149K	–	843
2014 Q1	$149K	Buy	+4,936	New	+$166K	﹤0.01%	603
2013 Q4	–	Sell	-11,291	Closed	-$310K	–	866
2013 Q3	$310K	Sell	11,291 -1,314	-10%	-$31.9K	0.01%	698
2013 Q2	$268K	Buy	+12,605	New	+$311K	0.01%	758

Other funds holding WINT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Oxford Asset Management's WINT Position: Q3 2015 in Review

Oxford Asset Management sold out of Windtree Therapeutics Inc (WINT) in Q3 2015, closing a stake of 10,504 shares — an estimated $100K sold.

Oxford Asset Management first reported a position in WINT in Q2 2013 and held it in 6 quarters. The position peaked at $310K in Q3 2013. 48 funds tracked by Wall St. Rank hold WINT as of Q3 2015.

Oxford Asset Management reported no remaining Windtree Therapeutics Inc position as of Q3 2015 after selling out during the quarter.
Oxford Asset Management sold 10,504 Windtree Therapeutics Inc shares in Q3 2015, an estimated $100K.
Oxford Asset Management first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 6 quarters.
Oxford Asset Management's Windtree Therapeutics Inc position peaked at $310K in Q3 2013.
48 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q3 2015.

Based on Oxford Asset Management's 13F filing for Q3 2015, filed 14 Oct 2015.